• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三磷酸腺苷敏感性测定在婴儿血管畸形中的应用。

Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies.

机构信息

Department of Dermatology, Beijing Children' s Hospital, Capital Medical University, National Center for Children' s Health, Beijing, 100045, China.

Department of Dermatovenereology, Maanshan people' s hospital, Maanshan, 243000, China.

出版信息

BMC Pediatr. 2020 Feb 19;20(1):78. doi: 10.1186/s12887-020-1974-9.

DOI:10.1186/s12887-020-1974-9
PMID:32075603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7029611/
Abstract

BACKGROUND

The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported.

OBJECTIVE

To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations.

METHODS

Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay.

RESULTS

Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells.

CONCLUSION

Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant.

摘要

背景

脉管性畸形包括各种血管肿瘤和血管畸形,其中婴幼儿血管瘤和毛细血管畸形是婴幼儿期最常见的相关疾病。已经引入了多种药物进行干预,但体外药敏试验报道甚少。

目的

在治疗婴幼儿血管瘤和毛细血管畸形之前,通过三磷酸腺苷敏感性测定体外评估不同药物的抑制作用。

方法

选取婴幼儿血管瘤 5 例,毛细血管畸形 11 例,用三磷酸腺苷敏感性测定法检测普萘洛尔、雷帕霉素、西地那非和伊曲康唑对其生长的抑制作用。

结果

普萘洛尔对婴幼儿血管瘤细胞有抑制作用。雷帕霉素和伊曲康唑均对婴幼儿血管瘤细胞和毛细血管畸形细胞有抑制作用。西地那非对婴幼儿血管瘤细胞或毛细血管畸形细胞无生长抑制作用。

结论

三磷酸腺苷敏感性测定是血管异常管理前一种敏感且有用的检测方法,根据检测结果和对每个患儿的综合评估,为选择治疗药物提供个体化的用药建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f0d/7029611/d897c2340925/12887_2020_1974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f0d/7029611/9254cf71dfd0/12887_2020_1974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f0d/7029611/d897c2340925/12887_2020_1974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f0d/7029611/9254cf71dfd0/12887_2020_1974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f0d/7029611/d897c2340925/12887_2020_1974_Fig2_HTML.jpg

相似文献

1
Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies.三磷酸腺苷敏感性测定在婴儿血管畸形中的应用。
BMC Pediatr. 2020 Feb 19;20(1):78. doi: 10.1186/s12887-020-1974-9.
2
Differential diagnosis of infantile hemangiomas.婴儿血管瘤的鉴别诊断。
Pediatr Ann. 2012 Aug;41(8):1-7. doi: 10.3928/00904481-20120727-09.
3
Infantile Hemangiomas and Vascular Anomalies.婴幼儿血管瘤和脉管畸形。
Pediatr Ann. 2024 Apr;53(4):e129-e137. doi: 10.3928/19382359-20240205-04. Epub 2024 Apr 1.
4
Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma.普萘洛尔治疗除婴儿血管瘤以外的血管异常。
J Craniofac Surg. 2017 Nov;28(8):2001-2003. doi: 10.1097/SCS.0000000000004166.
5
Management of vascular malformations and hemangiomas of the head and neck--an update.头颈部血管畸形和血管瘤的管理——最新进展
Curr Opin Otolaryngol Head Neck Surg. 2013 Apr;21(2):157-63. doi: 10.1097/MOO.0b013e32835e15a9.
6
Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited.皮肤血管异常与神经管缺陷相关:命名法和病理学再探讨。
Neurosurgery. 2011 Jul;69(1):112-8; discussion 118. doi: 10.1227/NEU.0b013e3182134360.
7
An update of 77 cases diagnosed as oral hemangiomas based on GLUT-1 positivity.基于葡萄糖转运蛋白1(GLUT-1)阳性确诊的77例口腔血管瘤病例的更新情况。
Exp Mol Pathol. 2017 Aug;103(1):9-13. doi: 10.1016/j.yexmp.2017.05.014. Epub 2017 May 22.
8
Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies.婴儿血管异常的临床特征及治疗选择
Medicine (Baltimore). 2015 Oct;94(40):e1717. doi: 10.1097/MD.0000000000001717.
9
Multifocal rapidly involuting congenital hemangioma: a link to chorangioma.多灶性快速消退先天性血管瘤:与绒毛膜血管瘤的关联。
Am J Med Genet A. 2007 Dec 15;143A(24):3038-46. doi: 10.1002/ajmg.a.31964.
10
[Infantile hemangioma : Clinical manifestation, treatment, and differential diagnoses].[婴儿血管瘤:临床表现、治疗及鉴别诊断]
Dermatologie (Heidelb). 2023 May;74(5):331-339. doi: 10.1007/s00105-023-05145-2.

引用本文的文献

1
Itraconazole inhibits proliferation, induces apoptosis, and reduces angiogenesis of hemangioma endothelial cells by downregulating the hedgehog signaling pathway.伊曲康唑通过下调刺猬信号通路来抑制血管瘤内皮细胞的增殖、诱导其凋亡并减少血管生成。
Heliyon. 2023 Aug 22;9(9):e19244. doi: 10.1016/j.heliyon.2023.e19244. eCollection 2023 Sep.
2
Itraconazole therapy for infant hemangioma: Two case reports.伊曲康唑治疗婴儿血管瘤:两例报告。
World J Clin Cases. 2021 Oct 6;9(28):8579-8586. doi: 10.12998/wjcc.v9.i28.8579.

本文引用的文献

1
Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.血管异常(第一部分):血管异常的分类与诊断
Rofo. 2018 Sep;190(9):825-835. doi: 10.1055/a-0620-8925. Epub 2018 Jun 6.
2
Topical propranolol for infantile haemangiomas: a systematic review.外用普萘洛尔治疗婴儿血管瘤:一项系统评价。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2083-2089. doi: 10.1111/jdv.14963. Epub 2018 May 3.
3
Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma.普萘洛尔治疗除婴儿血管瘤以外的血管异常。
J Craniofac Surg. 2017 Nov;28(8):2001-2003. doi: 10.1097/SCS.0000000000004166.
4
The anti-cancer effects of itraconazole in epithelial ovarian cancer.伊曲康唑在卵巢上皮性癌中的抗癌作用。
Sci Rep. 2017 Jul 26;7(1):6552. doi: 10.1038/s41598-017-06510-7.
5
Update on classification and diagnosis of vascular malformations.血管畸形的分类与诊断进展
Curr Opin Pediatr. 2017 Aug;29(4):448-454. doi: 10.1097/MOP.0000000000000518.
6
Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.阿替洛尔与普萘洛尔治疗增殖期婴儿血管瘤的回顾性非劣效性研究。
Pediatr Dermatol. 2017 Jul;34(4):413-421. doi: 10.1111/pde.13177. Epub 2017 May 28.
7
The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.局部用噻吗洛尔治疗婴儿血管瘤的作用:系统评价和荟萃分析。
Acta Derm Venereol. 2017 Nov 15;97(10):1167-1171. doi: 10.2340/00015555-2681.
8
Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.婴幼儿血管瘤:风险因素、发病机制和治疗的最新综述。
Birth Defects Res. 2017 Jul 3;109(11):809-815. doi: 10.1002/bdr2.1023. Epub 2017 Apr 12.
9
Infantile haemangioma.婴儿血管瘤。
Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13.
10
Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.β-肾上腺素能受体亚型在增殖期、消退期及对普萘洛尔有反应的婴儿血管瘤中的表达
JAMA Facial Plast Surg. 2017 Mar 1;19(2):102-107. doi: 10.1001/jamafacial.2016.1188.